732 results

N1-benzoyl-N2-[1-(1-naphthyl)ethyl]-trans-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (calhex 231) as a New Calcium Sensing Receptor Ligand Demonstrating Potent Calcilytic Activity

A structure-activity relationship (SAR) study was performed principally at the N1 position of N1-arylsulfonyl-N2-[1-(1-naphthyl)ethyl]-trans-1,2-diaminocyclohexanes, a new family of calcilytics acting at the calcium sensing receptor (CaSR). The most active compound in this series was the 4-(trifluoromethoxy)benzenesulfonyl derivative 7e, which displayed an IC50 of 5.4 ± 0.5 µM with respect to the inhibition of calcium-induced tritiated … Continued

https://www.certara.com/publication/n1-benzoyl-n2-1-1-naphthylethyl-trans-12-diaminocyclohexanes-development-of-4-chlorophenylcarboxamide-calhex-231-as-a-new-calcium-sensing-receptor-ligand-demonstrating-potent-calcilytic-activi/

Pharmacokinetics of Clofarabine in Patients with High-risk Inherited Metabolic Disorders Undergoing Brain-sparing Hematopoietic Cell Transplantation

Clofarabine, a newer purine analog with reduced central nervous system toxicity, may prove advantageous in hematopoietic cell transplantation in patients for whom neurotoxicity is a natural part of disease progression. This study evaluated clofarabine pharmacokinetics in adult and pediatric patients undergoing hematopoietic cell transplantation for the treatment of high-risk, inherited metabolic disorders. Clofarabine (40 mg/m(2)/d) … Continued

https://www.certara.com/publication/pharmacokinetics-of-clofarabine-in-patients-with-high-risk-inherited-metabolic-disorders-undergoing-brain-sparing-hematopoietic-cell-transplantation/

Application of PBPK Modeling to Predict Monoclonal Antibody Disposition in Plasma and Tissues in Mouse Models of Human Colorectal Cancer

This investigation evaluated the utility of a physiologically based pharmacokinetic (PBPK) model, which incorporates model parameters representing key determinants of monoclonal antibody (mAb) target-mediated disposition, to predict, a priori, mAb disposition in plasma and in tissues, including tumors that express target antigens. Monte Carlo simulation techniques were employed to predict the disposition of two mAbs, 8C2 (as a non-binding control mouse IgG1 mAb) and T84.66 (a high-affinity murine IgG1 anti-carcinoembryonic antigen … Continued

https://www.certara.com/publication/application-of-pbpk-modeling-to-predict-monoclonal-antibody-disposition-in-plasma-and-tissues-in-mouse-models-of-human-colorectal-cancer/

2D- and 3D-QSAR Studies on 54 Anti-tumor Rubiaceae-type Cyclopeptides

RA-VII, a bicyclic hexapeptide isolated from the roots of Rubia cordifolia, Rubia akane belongs to Rubiaceae-type cyclopeptides (RAs) and has attracted much attention for its potent anti-tumor activity and its bicyclic structure incorporating the isodityrosine moiety. In this work, hologram quantitative structure-activity relationship (HQSAR), comparative molecular field analysis (CoMFA), and comparative molecular similarity indices analysis … Continued

https://www.certara.com/publication/2d-and-3d-qsar-studies-on-54-anti-tumor-rubiaceae-type-cyclopeptides/

Design and Synthesis of 4-amino-2-phenylquinazolines as Novel Topoisomerase I Inhibitors with Molecular Modeling

4-Amino-2-phenylquinazolines 7 were designed as bioisosteres of 3-arylisoquinolinamines 6 that were energy minimized to provide stable conformers. Interestingly, the 2-phenyl ring of 4-amino-2-phenylquinazolines was parallel to the quinazoline ring and improved their DNA intercalation ability in the DNA-topo I complex.  

https://www.certara.com/publication/design-and-synthesis-of-4-amino-2-phenylquinazolines-as-novel-topoisomerase-i-inhibitors-with-molecular-modeling/

A Comparative Study of Quantitative Structure-activity Relationship Methods Based on Gallic Acid Derivatives

By using hologram quantitative structure-activity relationship (HQSAR) and comparative molecular field analysis (CoMFA) methods, the relationships between the structures of 49 gallic acid derivatives and their analgesic activity have been investigated to yield statistically reliable models with considerable predictive power. The best HQSAR model was generated using atoms, bond and connectivity as fragment distinction parameters … Continued

https://www.certara.com/publication/a-comparative-study-of-quantitative-structure-activity-relationship-methods-based-on-gallic-acid-derivatives/

Case Studies Addressing Human Pharmacokinetic Uncertainty Using a Combination of Pharmacokinetic Simulation and Alternative First-in-human

PF-184298 ((S)-2,3-dichloro-N-isobutyl-N-pyrrolidin-3-ylbenzamide) and PF-4776548 ((3-(4-fluoro-2-methoxy-benzyl)-7-hydroxy-8,9-dihydro-3H,7H-pyrrolo[2,3-c][1,7]naphthyridin-6-one)) are novel compounds which were selected to progress to human studies. Discordant human pharmacokinetic predictions arose from pre-clinical in vivo studies in rat and dog, and from human in vitro studies, resulting in a clearance prediction range of 3 to >20 mL min-1  kg-1 for PF-184298, and 5 to >20 mL min-1 … Continued

https://www.certara.com/publication/case-studies-addressing-human-pharmacokinetic-uncertainty-using-a-combination-of-pharmacokinetic-simulation-and-alternative-first-in-human/

Hologram Quantitative Structure Activity Relationship Studies on 5-HT6 Antagonists

Predictive hologram quantitative structure activity relationship (HQSAR) models were developed for a series of arylsulfonamide compounds acting as specific 5-HT6 antagonists. A training set containing 48 compounds served to establish the model. The best HQSAR model was generated using atoms, bond, and connectivity as fragment distinction and 4-7 as fragment size showing cross-validated r2(q2) value … Continued

https://www.certara.com/publication/hologram-quantitative-structure-activity-relationship-studies-on-5-ht6-antagonists/

Therapeutic Benefit of Eletriptan Compared to Sumatriptan for the Acute Relief of Migraine Pain—Results of a Model-based Meta-analysis that Accounts for Encapsulation

A novel model-based meta-analysis was used to quantify the dose-response relationship of sumatriptan and eletriptan for the proportion of patients that achieve migraine pain relief up to 4 h after treatment. The proportion of patients that became pain free was also evaluated. This analysis includes some unique features, allowing comparison of sumatriptan and eletriptan doses … Continued

https://www.certara.com/publication/therapeutic-benefit-of-eletriptan-compared-to-sumatriptan-for-the-acute-relief-of-migraine-pain-results-of-a-model-based-meta-analysis-that-accounts-for-encapsulation-2/

Application of Knockout Mouse Models to Investigate the Influence of FcγR on the Pharmacokinetics and Anti-platelet Effects of MWReg30, a Monoclonal Anti-GPIIb Antibody

This work evaluates the influence of FcγR on the pharmacokinetics and pharmacodynamics of a rat anti-integrin-αIIb IgG1 monoclonal antibody, MWReg30, in mice. The pharmacokinetics and pharmacodynamics of MWReg30 were investigated in C57BL/6 control mice, FcγRI/RIII knockout mice, and FcγRIIb knockout mice, following intravenous doses of 0.04-0.4mg/kg. MWReg30 treatment resulted in a dose-dependent induction of thrombocytopenia … Continued

https://www.certara.com/publication/application-of-knockout-mouse-models-to-investigate-the-influence-of-fc-gamma-r-on-the-pharmacokinetics-and-anti-platelet-effects-of-mwreg30-a-monoclonal-anti-gpiib-antibody/
1 of 74
Back to top